November 2 CBPP Spotlight | Case-Based Peer Perspectives Spotlight Live

Frontline Regimens Explored for EGFR-Mutated NSCLC

December 20, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspective event, John Heymach, MD, PhD Chair, Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center, discusses the case of a 73-year-old Asian patients with EGFR-mutant non–small cell lung cancer.

Comparing Immunochemotherapy Combinations in Patients With ES-SCLC

December 19, 2020

Clinical Articles

Jun Zhang, MD, PhD, associate professor, University of Kansas Medical Center, reviews the preferred treatment options for extensive-stage small cell lung cancer in a 73-year-old patient during a Targeted Oncology Case Based Peer Perspective event.

Different Staging, Risk Stratification, and Treatment Methods for Acute GVHD

December 17, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, Miguel-Angel Perales, MD, discussed testing for risk stratification and treatment of graft-versus-host-disease based on the case of a 48-year-old man.

Trials Demonstrate Which Treatments Physicians Should Use in EGFR+ NSCLC

December 14, 2020

Edgardo S. Santos Castillero, MD, reviewed the case of a 73-year-old Asian man who was diagnosed with stage IV EGFR-mutant non-small cell lung cancer and discussed the treatment options he would consider for this patient.

Multiple Studies Provide Efficacy Results for Lenvatinib in Thyroid Cancer

November 27, 2020

Clinical Articles

Matthew Taylor, MD, reviewed the clinical trials supporting levantinib as a treatment option for a patient with thyroid cancer and discussed the option with a group of oncologists during a Targeted Oncology Case Base Peer Perspectives event.

Ruxolitinib Controls Symptoms for Patients With Myelofibrosis

November 26, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, Rami Komrokji, MD, explored the use of ruxolitinib (Jakafi) for the treatment of a 68-year-old female patient with myelofibrosis.

In Patients With Relapsed/Refractory DLBCL, Tafasitamab/Lenalidomide Combo Shines

November 26, 2020

Clinical Articles

Kami J. Maddocks, MD, discussed the efficacy and safety of tafasitamab in combination with lenalidomide as treatment of a 74-year-old man with diffuse large B-cell lymphoma. The treatment option was discussed with a group of oncologists during a Targeted Oncology Case Based Peer Perspective event.

Morgans Discusses Therapy Options for Metastatic and Nonmetatstatic CRPC

November 24, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, Alicia K. Morgans, MD, MPH, reviewed 2 cases of patients with nonmetastatic castration resistant prostate cancer and explained the potential testing and treatment options.